SK Bioscience Co.,Ltd Logo

SK Bioscience Co.,Ltd

A biopharma firm developing and manufacturing vaccines and offering CDMO services.

302440 | KO

Overview

Corporate Details

ISIN(s):
KR7302440003
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 310, 성남시

Description

SK Bioscience is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines and biological products. Spun off from SK Chemicals in 2018, the company develops its own pipeline of vaccines, including cell-culture-based influenza vaccines and a COVID-19 vaccine, utilizing its established R&D and production platforms. In addition to its proprietary products, SK Bioscience provides global Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from process development to large-scale commercial manufacturing for international partners. The company is dedicated to promoting public health by providing innovative preventative solutions to address global health challenges.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-12-29 00:00
[기재정정]신규시설투자등
Korean HTML 12.9 KB
2025-12-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2025-12-26 00:00
최대주주등소유주식변동신고서
Korean HTML 25.0 KB
2025-12-23 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 14.5 KB
2025-09-19 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean HTML 47.1 KB
2025-09-19 00:00
특수관계인에대한부동산매도
Korean HTML 5.2 KB
2025-09-19 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 92.4 KB
2025-08-29 00:00
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean HTML 7.9 KB
2025-08-13 00:00
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean HTML 11.0 KB
2025-08-12 00:00
반기보고서 (2025.06)
Korean HTML 4.3 MB
2025-07-31 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 15.0 KB
2025-07-31 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.1 KB
2025-07-21 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.1 KB

Automate Your Workflow. Get a real-time feed of all SK Bioscience Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SK Bioscience Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SK Bioscience Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.